Renalytix Plc
RENX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£21,800 | -£33,456 | -£46,221 | -£49,628 |
| Dep. & Amort. | £0 | £364 | £508 | £489 |
| Deferred Tax | £0 | £0 | £3,366 | £0 |
| Stock-Based Comp. | £3,200 | £1,710 | £2,932 | £4,621 |
| Change in WC | -£3,300 | -£3,529 | £5,347 | -£2,256 |
| Other Non-Cash | £4,000 | £4,800 | -£17 | £1,029 |
| Operating Cash Flow | -£17,900 | -£30,111 | -£32,674 | -£45,745 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | -£4 | £0 | -£694 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £0 | -£4 | £0 | -£694 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£3,500 | -£1,660 | -£3,180 | £18,020 |
| Stock Issued | £19,500 | £13,626 | £20,557 | £9,210 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | -£1,716 | -£991 | -£1,715 |
| Financing Cash Flow | £16,000 | £10,250 | £16,386 | £25,515 |
| Forex Effect | £800 | -£137 | £905 | -£2,902 |
| Net Chg. in Cash | -£1,100 | -£20,002 | -£16,651 | -£23,826 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £4,700 | £24,682 | £41,333 | £65,159 |
| End Cash | £3,600 | £4,680 | £24,682 | £41,333 |
| Free Cash Flow | -£17,900 | -£30,115 | -£32,674 | -£46,439 |